Citadel Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.61M | Buy |
350,392
+22,567
| +7% | +$361K | ﹤0.01% | 1808 |
|
|
2025
Q1 | $5.6M | Sell |
327,825
-116,188
| -26% | -$1.99M | ﹤0.01% | 1659 |
|
|
2024
Q4 | $11M | Buy |
444,013
+104,092
| +31% | +$2.58M | ﹤0.01% | 1266 |
|
|
2024
Q3 | $9.69M | Sell |
339,921
-3,591
| -1% | -$102K | ﹤0.01% | 1285 |
|
|
2024
Q2 | $9.07M | Buy |
343,512
+115,013
| +50% | +$3.04M | ﹤0.01% | 1264 |
|
|
2024
Q1 | $7.38M | Sell |
228,499
-582,940
| -72% | -$18.8M | ﹤0.01% | 1482 |
|
|
2023
Q4 | $34.2M | Sell |
811,439
-33,937
| -4% | -$1.43M | 0.01% | 618 |
|
|
2023
Q3 | $32.5M | Buy |
845,376
+539,527
| +176% | +$20.7M | 0.01% | 592 |
|
|
2023
Q2 | $5.8M | Sell |
305,849
-860,027
| -74% | -$16.3M | ﹤0.01% | 1602 |
|
|
2023
Q1 | $18.1M | Buy |
1,165,876
+193,154
| +20% | +$3M | ﹤0.01% | 902 |
|
|
2022
Q4 | $17.3M | Buy |
972,722
+901,589
| +1,267% | +$16M | ﹤0.01% | 951 |
|
|
2022
Q3 | $397K | Sell |
71,133
-38,872
| -35% | -$217K | ﹤0.01% | 4294 |
|
|
2022
Q2 | $429K | Sell |
110,005
-114,586
| -51% | -$447K | ﹤0.01% | 4295 |
|
|
2022
Q1 | $1.24M | Sell |
224,591
-23,170
| -9% | -$128K | ﹤0.01% | 3540 |
|
|
2021
Q4 | $2.11M | Buy |
247,761
+79,018
| +47% | +$673K | ﹤0.01% | 2994 |
|
|
2021
Q3 | $1.47M | Sell |
168,743
-6,669
| -4% | -$57.9K | ﹤0.01% | 3352 |
|
|
2021
Q2 | $1.85M | Sell |
175,412
-384,929
| -69% | -$4.07M | ﹤0.01% | 3291 |
|
|
2021
Q1 | $8.99M | Sell |
560,341
-208,693
| -27% | -$3.35M | ﹤0.01% | 1522 |
|
|
2020
Q4 | $35.5M | Buy |
769,034
+67,959
| +10% | +$3.14M | 0.01% | 577 |
|
|
2020
Q3 | $24.7M | Buy |
701,075
+487,423
| +228% | +$17.2M | 0.01% | 661 |
|
|
2020
Q2 | $5.2M | Buy |
213,652
+195,896
| +1,103% | +$4.77M | ﹤0.01% | 1494 |
|
|
2020
Q1 | $276K | Buy |
+17,756
| New | +$276K | ﹤0.01% | 3856 |
|